You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AT101

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B-cell Non Hodgkin Lymphoma Trial in Seoul (AT101(Anti-CD19 Chimeric Antigen Receptor T cell))

Recruiting
  • B-cell Non Hodgkin Lymphoma
  • AT101(Anti-CD19 Chimeric Antigen Receptor T cell)
  • Seoul, Korea, Republic of
    Asan Medical Center
May 24, 2022

Laryngeal Cancer Trial in Ann Arbor (AT-101, Docetaxel, Cisplatin)

Completed
  • Laryngeal Cancer
  • Ann Arbor, Michigan
    University of Michigan Comprehensive Cancer Center
Dec 17, 2021

Recurrent Plasma Cell Myeloma Trial in Jacksonville (Dexamethasone, Laboratory Biomarker Analysis, Lenalidomide)

Active, not recruiting
  • Recurrent Plasma Cell Myeloma
  • Jacksonville, Florida
    Mayo Clinic in Florida
Jan 4, 2023

Bipolar Depression, Bipolar Affective Disorder Trial (NRX-101)

Available
  • Bipolar Depression
  • Bipolar Affective Disorder
  • (no location specified)
Mar 22, 2023

Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis Trial in United States (Biospecimen

Recruiting
  • Recurrent Langerhans Cell Histiocytosis
  • Refractory Langerhans Cell Histiocytosis
  • Biospecimen Collection
  • +8 more
  • Wilmington, Delaware
  • +3 more
Apr 28, 2023

Sickle Cell Disease Trial in Birmingham, Palo Alto, Saint Louis (GPH101 Drug Product)

Active, not recruiting
  • Sickle Cell Disease
  • GPH101 Drug Product
  • Birmingham, Alabama
  • +2 more
Jan 5, 2023

Pompe Disease Trial in Saint Louis, New York, Durham (ACTUS-101)

Recruiting
  • Pompe Disease
  • ACTUS-101
  • Saint Louis, Missouri
  • +2 more
May 25, 2022

Peripheral T Cell Lymphoma (PTCL), Cell Therapy Trial in United States (MT-101, MT-101 + Conditioning (Lymphodepleting)

Recruiting
  • Lymphoma, T-Cell, Peripheral
  • +4 more
  • MT-101
  • MT-101 + Conditioning (Lymphodepleting) Chemotherapy
  • Duarte, California
  • +8 more
Jan 27, 2023

Bariatric Surgery, Obesity, Weight Gain Trial in San Diego (ARD-101)

Recruiting
  • Bariatric Surgery
  • +2 more
  • San Diego, California
    Altman Clinical and Translational Research Institute, University
Apr 21, 2022

Advanced Solid Tumor Trial in United States (XTX101, Pembrolizumab)

Recruiting
  • Advanced Solid Tumor
  • Encinitas, California
  • +9 more
Jun 30, 2022

Breast Cancer, Head and Neck Squamous Cell Carcinoma, Non Small Cell Lung Cancer Trial in Atlanta, Houston, San Antonio

Recruiting
  • Breast Cancer
  • +7 more
  • Atlanta, Georgia
  • +2 more
Jun 13, 2022

Fluid Retention, Sodium Retention, Heat Stress Trial in Storrs (PR Lotion - AMP Human Performance, Placebo Lotion, AminoVital -

Recruiting
  • Fluid Retention
  • +5 more
  • PR Lotion - AMP Human Performance
  • +3 more
  • Storrs, Connecticut
    Korey Stringer Institute at the University of Connecticut
May 19, 2022

Metastatic HER2 Positive Gastroesophageal Junction Cancer Trial in La Jolla, Washington, Hackensack (CYNK-101, Pembrolizumab,

Recruiting
  • Metastatic HER2 Positive Gastroesophageal Junction Cancer
  • CYNK-101
  • +6 more
  • La Jolla, California
  • +2 more
Jul 12, 2022

Coronary Artery Disease Trial in Reykjavik (A digital care solution for patients with Coronary Artery Disease, Standard of care

Recruiting
  • Coronary Artery Disease
  • A digital care solution for patients with Coronary Artery Disease
  • Standard of care for patients with Coronary Artery Disease
  • Reykjavik, Iceland
    Landspítali University Hospital
Feb 8, 2023

Cancer, Covid-19 Trial in Canada (IMM-101, Observation)

Active, not recruiting
  • Cancer
  • Covid-19
  • IMM-101
  • Observation
  • Hamilton, Ontario, Canada
  • +7 more
Jun 23, 2022

SMA Trial in Worldwide (Onasemnogene Abeparvovec-xioi)

Completed
Has Results
  • SMA
  • Onasemnogene Abeparvovec-xioi
  • Ghent, Belgium
  • +9 more
Aug 12, 2022

GVHD, Chronic Trial in China (BN101)

Recruiting
  • GVHD, Chronic
  • Beijing, China
  • +7 more
Apr 24, 2022

Evaluating the Safety of CS20AT04 in Lupus Nephritis

Active, not recruiting
  • Lupus Nephritis
    • Seoul, Korea, Republic of
      Hanyang university hospital
    Mar 8, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Scottsdale, Jacksonville, Rochester (drug, other, biological)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Scottsdale, Arizona
    • +2 more
    Jan 5, 2023

    Healthy Trial in London (ALXN1840)

    Completed
    • Healthy
    • London, United Kingdom
      Clinical Trial Site
    Apr 1, 2022

    Alpha 1-Antitrypsin Deficiency, Emphysema Trial in Australia, United States (INBRX-101, Zemaira)

    Recruiting
    • Alpha 1-Antitrypsin Deficiency
    • Emphysema
    • Birmingham, Alabama
    • +25 more
    May 11, 2023

    Relapsed/Refractory AML, AML, Adult, MDS Trial in United States (NKX101 - CAR NK cell therapy)

    Recruiting
    • Relapsed/Refractory AML
    • +3 more
    • NKX101 - CAR NK cell therapy
    • Denver, Colorado
    • +6 more
    Apr 8, 2022

    Advanced Solid Tumor Trial in Los Angeles (EP0031)

    Recruiting
    • Advanced Solid Tumor
    • Los Angeles, California
    • +3 more
    Dec 1, 2022

    Lipid Disorder, Triglycerides High, Dyslipidemias Trial in Philadelphia (Icosapent Ethyl 1000 MG [Vascepa])

    Completed
    Has Results
    • Lipid Disorder
    • +2 more
    • Icosapent Ethyl 1000 MG [Vascepa]
    • Philadelphia, Pennsylvania
      Perelman School of Medicine at the University of Pennsylvania
    Oct 15, 2021

    Prostatic Tumors, Castration-Resistant, Tumors by Histologic Type, Tumors, Prostate Trial in United States (P-PSMA-101 CAR-T

    Active, not recruiting
    • Prostatic Neoplasms, Castration-Resistant
    • +16 more
    • Duarte, California
    • +9 more
    Nov 15, 2022